0001562180-24-003735.txt : 20240502 0001562180-24-003735.hdr.sgml : 20240502 20240502172909 ACCESSION NUMBER: 0001562180-24-003735 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240501 FILED AS OF DATE: 20240502 DATE AS OF CHANGE: 20240502 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Jung Melita Sun CENTRAL INDEX KEY: 0001962407 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39926 FILM NUMBER: 24909974 MAIL ADDRESS: STREET 1: C/O STRUCTURE THERAPEUTICS INC. CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Terns Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001831363 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1065 EAST HILLSDALE BLVD., SUITE 100 CITY: FOSTER CITY STATE: CA ZIP: 94404 BUSINESS PHONE: 650-525-5535 EXT.101 MAIL ADDRESS: STREET 1: 1065 EAST HILLSDALE BLVD., SUITE 100 CITY: FOSTER CITY STATE: CA ZIP: 94404 4 1 primarydocument.xml PRIMARY DOCUMENT X0508 4 2024-05-01 false 0001831363 Terns Pharmaceuticals, Inc. TERN 0001962407 Jung Melita Sun C/O TERNS PHARMACEUTICALS, INC. 1065 EAST HILLSDALE BLVD., SUITE 100 FOSTER CITY CA 94404 false true false false Chief Business Officer false Stock Option (Right to buy) 5.08 2024-05-01 4 A false 475000.00 0.00 A 2034-04-30 Common Stock 475000.00 475000.00 D 25% of the shares subject to the option vest on the first anniversary measured from May 1, 2024 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested on the fourth anniversary of the Vesting Commencement Date. /s/ Bryan Yoon, as Attorney-in-Fact for Melita Sun Jung 2024-05-02